DBV Technologies - Aktienkurs

Aktienkurs
9.33
Täglich Wechseln
0.38 4.25%
Monatlich
25.40%
Jährlich
1,292.54%
Q2 Prognose
8.79


Preis Chg Tag Jahr Datum
Acadia Pharmaceuticals 15.26 0.35 2.35% -10.24% 2025-05-05
Alnylam Pharmaceuticals 271.10 11.71 4.51% 79.45% 2025-05-05
Amarin 10.59 -0.32 -2.93% 980.61% 2025-05-05
BioMarin Pharmaceutical 62.24 0.21 0.34% -24.18% 2025-05-05
DBV Technologies 9.33 0.38 4.25% 1,292.54% 2025-05-05
Halozyme Therapeutics 60.72 -0.47 -0.77% 48.61% 2025-05-05
Incyte 62.10 -0.43 -0.69% 14.84% 2025-05-05
Insmed 72.78 0.48 0.66% 180.46% 2025-05-05
Ionis Pharmaceuticals 33.61 0.83 2.53% -20.52% 2025-05-05
Neurocrine Biosciences 110.71 1.03 0.94% -21.88% 2025-05-05
PTC Therapeutics 41.27 -8.68 -17.38% 25.21% 2025-05-05
Ultragenyx Pharmaceutical 39.10 -0.20 -0.51% -9.09% 2025-05-05
Sarepta Therapeutics 64.40 0.89 1.40% -52.30% 2025-05-05
United Therapeutics 298.52 3.92 1.33% 14.59% 2025-05-05

Preis Tag Jahr Datum
USND 17844 -133.49 -0.74% 9.14% 2025-05-05